A comparison of liver function after hepatectomy with inflow occlusion between sevoflurane and propofol anesthesia

Anesthesia and Analgesia

Volumn 111, Issue 4, 2010, Pages 1036-1041

  Song, J C ^a   Sun, Y M ^a   Yang, L Q ^a   Zhang, M Z ^b   Lu, Z J ^a   Yu, W F ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; ATROPINE; BILIRUBIN; CISATRACURIUM; CREATININE; FENTANYL; MIDAZOLAM; PROPOFOL; ROPIVACAINE; SEVOFLURANE; SUFENTANIL; TRAMADOL; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANESTHESIA INDUCTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ELECTIVE SURGERY; GENERAL ANESTHESIA; HUMAN; INFLOW OCCLUSION; INHALATION ANESTHESIA; LENGTH OF STAY; LEUKOCYTE COUNT; LIVER FUNCTION TEST; LIVER INJURY; LIVER RESECTION; MAJOR CLINICAL STUDY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SURGICAL PATIENT; SURGICAL TECHNIQUE; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; LIVER; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; VASCULARIZATION;

ADULT; ANESTHESIA, GENERAL; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; FEMALE; HEPATECTOMY; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; METHYL ETHERS; MIDDLE AGED; PROPOFOL;

EID: 77957713870     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181effda8     Document Type: Article

References (24)

1. Gozzetti G, Mazziotti A, Grazi GL, Jovine E, Gallucci A, Gruttadauria S, Frena A, Morganti M, Ercolani G, Masetti M, Pierangeli F. Liver resection without blood transfusion. Br J Surg 1995;82:1105-1110
2. Kooby DA, Stockman J, Ben-Porat L, Gonen M, Jarnagin WR, Dematteo RP, Tuorto S, Wuest D, Blumgart LH, Fong Y. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003;237:860-870
3. van der Bilt JD, Livestro DP, Borren A, van Hillegersberg R, Borel Rinkes IH. European survey on the application of vascular clamping in liver surgery. Dig Surg 2007;24:423-435
4. Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000;232:155-162
5. Lesurtel M, Selzner M, Petrowsky H, McCormack L, Clavien PA. How should transection of the liver be performed? A prospective randomized study in 100 consecutive patients: comparing four different transection strategies. Ann Surg 2005;242:814-823
6. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007;356:1545-1559
7. Wei AC, Tung-Ping Poon R, Fan ST, Wong J. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 2003;90:33-41
8. Coelho JC, Claus CM, Machuca TN, Sobottka WH, Gonçalves CG. Liver resection: 10-year experience from a single institution. Arq Gastroenterol 2004;41:229-233
9. Clavien PA, Selzner M, Rudie;diger HA, Graf R, Kadry Z, Rousson V, Jochum W. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003;238:843-852
10. Lerman J. Study design in clinical research: sample size estimation and power analysis. Can J Anaesth 1996;43:184-191
11. Petrowsky H, McCormack L, Trujillo M, Selzner M, Jochum W, Clavien PA. A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg 2006;244:921-930
12. Ebert TJ, Arain SR. Renal responses to low-flow desflurane, sevoflurane, and propofol in patients. Anesthesiology 2000; 93:1401-1406
13. Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M, Jochum W, Spahn DR, Graf R, Clavien PA. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008;248:909-918
14. Bedirli N, Ofluoglu E, Kerem M, Utebey G, Alper M, Yilmazer D, Bedirli A, Ozlu O, Pasaoglu H. Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model. Anesth Analg 2008;106:830-837
15. Imai M, Kon S, Inaba H. Effects of halothane, isoflurane and sevoflurane on ischemia-reperfusion injury in the perfused liver of fasted rats. Acta Anasthesiol Scand 1996;40:1242-1248
16. De La Cruz JP, Sedeno G, Carmona JA, Sánchez de la Cuesta F. The in vitro effects of propofol on tissular oxidative stress in the rat. Anesth Analg 1998;87:1141-1146
17. Kharasch ED, Armstrong AS, Gunn K, Artru A, Cox K, Karol MD. Clinical sevoflurane metabolism and disposition. II. The role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation. Anesthesiology 1995;82:1379-1388
18. Liu KX, Chen SQ, Huang WQ, Li YS, Irwin MG, Xia Z. Propofol pretreatment reduces ceramide production and attenuates intestinal mucosal apoptosis induced by intestinal ischemia/reperfusion in rats. Anesth Analg 2008;107: 1884-1891
19. Navapurkar VU, Skepper JN, Jones JG, Menon DK. Propofol preserves the viability of isolated rat hepatocyte suspensions under an oxidant stress. Anesth Analg 1998;87:1152-1157
20. Wang H, Xue Z, Wang Q, Feng X, Shen Z. Propofol protects hepatic L02 cells from hydrogen peroxide-induced apoptosis via activation of extracellular signal-regulated kinases pathway. Anesth Analg 2008;107:534-540
21. Shimono H, Goromaru T, Kadota Y, Tsurumaru T, Kanmura Y. Propofol displays no protective effect against hypoxia/ reoxygenation injury in rat liver slices. Anesth Analg 2003;97:442-448
22. Kim YI, Kobayashi M, Aramaki M, Nakashima K, Mitarai Y, Yoshida T. "Early-stage" cirrhotic liver can withstand 75 minutes of inflow occlusion during resection. Hepatogastroenterology 1994;41:355-358
23. Kim YI, Nakashima K, Tada I, Kawano K, Kobayashi M. Prolonged normothermic ischaemia of human cirrhotic liver during hepatectomy: a preliminary report. Br J Surg 1993;80:1566-1570
24. Jeppsson B. Liver resection: prolonged inflow occlusion in human cirrhotic livers. HPB Surg 1996;10:123-125